Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to -$6.2 million.

  • GeoVax Labs' Free Cash Flow rose 3333.09% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.3 million, marking a year-over-year increase of 1081.57%. This contributed to the annual value of -$24.7 million for FY2024, which is 208.71% up from last year.
  • According to the latest figures from Q3 2025, GeoVax Labs' Free Cash Flow is -$6.2 million, which was up 3333.09% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, GeoVax Labs' Free Cash Flow registered a high of -$1.3 million during Q2 2021, and its lowest value of -$10.3 million during Q4 2023.
  • Its 5-year average for Free Cash Flow is -$5.1 million, with a median of -$5.1 million in 2023.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 48176.38% in 2021, then skyrocketed by 6797.45% in 2024.
  • Over the past 5 years, GeoVax Labs' Free Cash Flow (Quarter) stood at -$6.7 million in 2021, then fell by 5.7% to -$7.1 million in 2022, then plummeted by 45.76% to -$10.3 million in 2023, then rose by 24.7% to -$7.8 million in 2024, then rose by 19.88% to -$6.2 million in 2025.
  • Its Free Cash Flow stands at -$6.2 million for Q3 2025, versus -$4.3 million for Q2 2025 and -$6.0 million for Q1 2025.